[ad_1] Allergan acquired regenerative medicine company LifeCell for $ 2.9 billion in cash, the company said on Tuesday. The deal is expected to be finalized early next year. LifeCell’s products include acellular dermal matrices, most commonly used in breast reduction procedures and hernia surgeries. LifeCell has manufacturing capabilities and R&D …

Read More »